SR26334

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
012319982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVES To compare the absorption of 300 mg clopidogrel administered crushed via nasogastric (NG) tube versus whole tablets… (More)
Is this relevant?
2009
2009
BACKGROUND Clopidogrel, a potent antiplatelet agent, reduces the risk for thrombotic events in patients with atherothrombotic… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Prasugrel and clopidogrel, thienopyridine prodrugs, are each metabolized to an active metabolite that inhibits the platelet P2Y… (More)
Is this relevant?
2008
2008
Clopidogrel is activated by cytochrome P450 3A (CYP3A) to generate an active metabolite that inhibits adenosine diphosphate (ADP… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2008
2008
A high throughput liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS-MS) method is developed for… (More)
Is this relevant?
2006
2006
A new, sensitive, specific and reproducible method for determination of clopidogrel metabolite (SR26334) in human plasma has been… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Clopidogrel is extensively metabolized, as evidenced by the absence of detectable amounts of unchanged clopidogrel in plasma… (More)
Is this relevant?
1999
1999
Two open, randomized, crossover bioavailability studies were carried out to assess the influence of concurrent antacid medication… (More)
Is this relevant?
1999
1999
The pharmacodynamic and pharmacokinetic effects of clopidogrel 75 mg taken once daily in the morning before breakfast for 10 days… (More)
Is this relevant?
1998
1998
This paper describes a GC-MS method for the analysis of the carboxylic acid metabolite (SR26334, II) of methyl (+)-(S)-alpha-(o… (More)
Is this relevant?